英菲格拉替尼国内上市了吗？英菲格拉替尼是什么药？

The U.S. FDA has accepted a new drug application for an oral FGFR1-3 selective inhibitor in 2020. The drug is mainly used to treat cholangiocarcinoma. The FDA has also granted the drug priority review status. Today, let’s take a detailed look at whether infigratinib has been launched in China? What is Infigratinib?

Cholangiocarcinoma refers to a malignant tumor originating from the extrahepatic bile duct, including the bile duct from the portal area to the lower end of the common bile duct, and has a very poor prognosis. Infigratinib is an orally administered selective fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor. The drug is indicated for previously treated, unresectable locally advanced or metastatic cholangiocarcinoma. It has a significant effect and can prolong the survival of patients and improve their quality of life. However, patients need to note that before using infigratinib, it is necessary to determine whether there is FGFR2 gene fusion or rearrangement, otherwise the drug is not allowed to be used.

Although Infigratinib has been marketed abroad, domestic data shows that the drug is an unmarketed drug. Patients cannot buy this drug in domestic hospital pharmacies. Purchasing drugs abroad will increase the financial burden, and they may not be able to buy real drugs. The editor recommends that patients obtain the drug through medical companion travel, which is cost-effective. You can buy the overseas version of Infigratinib without going abroad, and you can guarantee that the drug is genuine. Medical Companion Travel is favored by many domestic patients, and purchasing medicine through Medical Companion Travel is guaranteed. Patients can consult the medical companion passenger service staff for specific drug costs and drug purchase procedures.

Generally speaking, infigratinib is a drug for the treatment of cholangiocarcinoma. Patients should use it symptomatically and should not change the dosage and usage at will to avoid intolerance reactions. Patients should build confidence, maintain a calm mood, and cooperate with the doctor's treatment to achieve the best effect of the drug.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: